Roles for vitamin K beyond coagulation

Annual Review of Nutrition

Volumn 29, Issue , 2009, Pages 89-110

  Booth, Sarah L ^a  

^a TUFTS UNIVERSITY   (United States)

Author keywords

Calcification; Menaquinones; Osteoporosis; Phylloquinone; Vitamin K

Indexed keywords

CALCIUM; FARNOQUINONE; GLUTAMIC ACID; GROWTH ARREST SPECIFIC PROTEIN 6; MENAQUINONE; MENAQUINONE 7; MENATETRENONE; OSTEOCALCIN; PHYTOMENADIONE; TRANSCRIPTION FACTOR RUNX2; UNCLASSIFIED DRUG; VITAMIN D; VITAMIN K GROUP;

BLOOD CLOTTING; BLOOD VESSEL CALCIFICATION; CARBOXYLATION; CLINICAL TRIAL; DRUG EFFECT; DRUG EFFICACY; FRACTURE; FRAGILITY FRACTURE; HIP FRACTURE; HUMAN; INFLAMMATION; OSTEOPENIA; OSTEOPOROSIS; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; VITAMIN BLOOD LEVEL; VITAMIN INTAKE;

CARDIOVASCULAR DISEASES; DIETARY SUPPLEMENTS; ENERGY METABOLISM; EVIDENCE-BASED MEDICINE; HUMANS; INFLAMMATION; OSTEOPOROSIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; VITAMIN K;

EID: 67749093218     PISSN: 01999885     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev-nutr-080508-141217     Document Type: Review

References (142)

1. Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc. 2001. Washington, DC: Inst. Med., Natl. Acad. Press
2. Arbour NC, Darwish HM, DeLuca HF. 1995. Transcriptional control of the osteocalcin gene by 1,25-dihydroxyvitamin D-2 and its 24-epimer in rat osteosarcoma cells. Biochim. Biophys. Acta 1263:147-53
3. Arjmandi BH, Getlinger MJ, Goyal NV, Alekel L, Hasler CM, et al. 1998. Role of soy protein with normal or reduced isoflavone content in reversing bone loss induced by ovarian hormone deficiency in rats. Am. J. Clin. Nutr. 68:1358-63S
4. Ashwell M, Stone E, Mathers J, Barnes S, Compston J, et al. 2008. Nutrition and bone health projects funded by the UK Food Standards Agency: Have they helped to inform public health policy? Br. J. Nutr. 99:198-205
5. Avgeri M, Papadopoulou A, Platokouki H, Douros K, Rammos S, et al. 2008. Assessment of bone mineral density and markers of bone turnover in children under long-term oral anticoagulant therapy. J. Pediatr. Hematol. Oncol. 30:592-97
6. Barnes PJ, Karin M. 1997. Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N. Engl. J. Med. 336:1066-71
7. Beavan SR, Prentice A, Stirling DM, Dibba B, Yan L, et al. 2005. Ethnic differences in osteocalcin gamma-carboxylation, plasma phylloquinone (vitamin K1) and apolipoprotein E genotype. Eur. J. Clin. Nutr. 59:72-81
8. Binkley N, Harke J, Krueger D, Engelke J, Vallarta-Ast N, et al. 2008. Vitamin K treatment reduces undercarboxylated osteocalcin but does not alter bone turnover, density or geometry in healthy postmenopausal North American women. J. Bone Miner. Res. Epub ahead of print
9. Binkley NC, Krueger DC, Kawahara TN, Engelke JA, Chappell RJ, Suttie JW. 2002. A high phylloquinone intake is required to achieve maximal osteocalcin gamma-carboxylation. Am. J. Clin. Nutr. 76:1055-60
10. Bolton-Smith C, McMurdo ME, Paterson CR, Mole PA, Harvey JM, et al. 2007. Two-year randomized controlled trial of vitamin K1 (phylloquinone) and vitamin D3 plus calcium on the bone health of older women. J. Bone Miner. Res. 22:509-19
11. Bolton-Smith C, Price RJ, Fenton ST, Harrington DJ, Shearer MJ. 2000. Compilation of a provisional UK database for the phylloquinone (vitamin K1) content of foods. Br. J. Nutr. 83:389-99
12. Booth S, Broe K, Gagnon D, Tucker K, Hannan M, et al. 2003. Vitamin K intake and bone mineral density in women and men. Am. J. Clin. Nutr. 77:512-16
13. Booth SL, Al Rajabi A. 2008. Determinants of vitamin K status in humans. Vitam. Horm. 78:1-22
14. Booth SL, Broe KE, Peterson JW, Cheng DM, Dawson-Hughes B, et al. 2004. Associations between vitamin K biochemical measures and bone mineral density in men and women. J. Clin. Endocrinol. Metab. 89:4904-9
15. Booth SL, Dallal G, Shea MK, Gundberg C, Peterson JW, Dawson-Hughes B. 2008. Effect of vitamin K supplementation on bone loss in elderly men and women. J. Clin. Endocrinol. Metab. 93:1217-23
16. Booth SL, Martini L, Peterson JW, Saltzman E, Dallal GE, Wood RJ. 2003. Dietary phylloquinone depletion and repletion in older women. J. Nutr. 133:2565-69
17. Booth SL, O'Brien-Morse ME, Dallal GE, Davidson KW, Gundberg CM. 1999. Response of vitamin K status to different intakes and sources of phylloquinone-rich foods: comparison of younger and older adults. Am. J. Clin. Nutr. 70:368-77
18. Booth SL, Suttie JW. 1998. Dietary intake and adequacy of vitamin K. J. Nutr. 128:785-88
19. Booth SL, Tucker KL, Chen H, Hannan MT, Gagnon DR, et al. 2000. Dietary vitamin K intakes are associated with hip fracture but not with bone mineral density in elderly men and women. Am. J. Clin. Nutr. 71:1201-8
20. Booth SL, Tucker KL, McKeown NM, Davidson KW, Dallal GE, Sadowski JA. 1997. Relationships between dietary intakes and fasting plasma concentrations of fat-soluble vitamins in humans. J. Nutr. 127:587-92
21. Boskey AL, Gadaleta S, Gundberg C, Doty SB, Ducy P, Karsenty G. 1998. Fourier transform infrared microspectroscopic analysis of bones of osteocalcin-deficient mice provides insight into the function of osteocalcin. Bone 23:187-96
22. Braam LA, Dissel P, Gijsbers BL, Spronk HM, Hamulyak K, et al. 2000. Assay for human matrix Gla protein in serum: potential applications in the cardiovascular field. Arterioscler. Thromb. Vasc. Biol. 20:1257-61
23. Braam LA, Hoeks AP, Brouns F, Hamulyak K, Gerichhausen MJ, Vermeer C. 2004. Beneficial effects of vitamins D and K on the elastic properties of the vessel wall in postmenopausal women: a follow-up study. Thromb. Haemost. 91:373-80
24. Braam LA, Knapen MH, Geusens P, Brouns F, Hamulyak K, et al. 2003. Vitamin K1 supplementation retards bone loss in postmenopausal women between 50 and 60 years of age. Calcif. Tissue Int. 73:21-26
25. Braam LA, Knapen MH, Geusens P, Brouns F, Vermeer C. 2003. Factors affecting bone loss in female endurance athletes: a two-year follow-up study. Am. J. Sports Med. 31:889-95
26. Budoff MJ, Nasir K, Mao S, Tseng PH, Chau A, et al. 2006. Ethnic differences of the presence and severity of coronary atherosclerosis. Atherosclerosis 187:343-50
27. Cairns JR, Price PA. 1994. Direct demonstration that the vitamin K-dependent bone Gla protein is incompletely gamma-carboxylated in humans. J. Bone Miner. Res. 9:1989-97
28. Caraballo PJ, Gabriel SE, Castro MR, Atkinson EJ, Melton LJ 3rd. 1999. Changes in bone density after exposure to oral anticoagulants: a meta-analysis. Osteoporos. Int. 9:441-48
29. Cashman KD, O'Connor E. 2008. Does high vitamin K1 intake protect against bone loss in later life? Nutr. Rev. 66:532-38
30. Cauley JA, Zmuda JM, Yaffe K, Kuller LH, Ferrell RE, et al. 1999. Apolipoprotein E polymorphism: a new genetic marker of hip fracture risk-The Study of Osteoporotic Fractures. J. Bone Miner. Res. 14:1175-81
31. Chawla D, Deorari AK, Saxena R, Paul VK, Agarwal R, et al. 2007. Vitamin K1 versus vitamin K3 for prevention of subclinical vitamin deficiency: a randomized controlled trial. Indian Pediatr. 44:817-22
32. Cheung AM, Tile L, Lee Y, Tomlinson G, Hawker G, et al. 2008. Vitamin K supplementation in postmenopausal women with osteopenia (ECKO Trial): a randomized controlled trial. PLoS Med. 5:e196
33. Cockayne S, Adamson J, Lanham-New S, Shearer MJ, Gilbody S, Torgerson DJ. 2006. Vitamin K and the prevention of fractures: systematic review and meta-analysis of randomized controlled trials. Arch. Intern. Med. 166:1256-61
34. Conway SP, Wolfe SP, Brownlee KG, White H, Oldroyd B, et al. 2005. Vitamin K status among children with cystic fibrosis and its relationship to bone mineral density and bone turnover. Pediatrics 115:1325-31
35. Corella D, Ordovas JM. 2005. Single nucleotide polymorphisms that influence lipid metabolism: interaction with dietary factors. Annu. Rev. Nutr. 25:341-90
36. Coutu DL, Wu JH, Monette A, Rivard GE, Blostein MD, Galipeau J. 2008. Periostin, a member of a novel family of vitamin K-dependent proteins, is expressed by mesenchymal stromal cells. J. Biol. Chem. 283:17991-8001
37. Crosier MD, Booth SL, Peter I, Dawson-Hughes B, Price PA, et al. 2009. Matrix Gla polymorphisms are associated with coronary artery calcification in men. J. Nutr. Sci. Vitaminol. (Tokyo). In press
38. Crosier MD, Peter I, Booth SL, Bennett G, Dawson-Hughes B, Ordovas JM. 2009. Association of sequence variations in vitamin K epoxide reductase and gamma-glutamyl carboylase genes with biochemical measures of vitamin K status. J. Nutr. Sci. Vitaminol. (Tokyo). In press
39. Danziger J. 2008. Vitamin K-dependent proteins, warfarin, and vascular calcification. Clin. J. Am. Soc. Nephrol. 3:1504-10
40. Dawson-Hughes B, Harris SS, Krall EA, Dallal GE. 1997. Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. N. Engl. J. Med. 337:670-76
41. Ducy P, Desbois C, Boyce B, Pinero G, Story B, et al. 1996. Increased bone formation in osteocalcin-deficient mice. Nature 382:448-52
42. Elder SJ, Haytowitz DB, Howe J, Peterson JW, Booth SL. 2006. Vitamin K contents of meat, dairy, and fast food in the U.S. diet. J. Agric. Food Chem. 54:463-67
43. Erkkila AT, Booth SL. 2008. Vitamin K intake and atherosclerosis. Curr. Opin. Lipidol. 19:39-42
44. Erkkila AT, Booth SL, Hu FB, Jacques PF, Lichtenstein AH. 2007. Phylloquinone intake and risk of cardiovascular diseases in men. Nutr. Metab. Cardiovasc. Dis. 17:58-62
45. Erkkila AT, Booth SL, Hu FB, Jacques PF, Manson JE, et al. 2005. Phylloquinone intake as a marker for coronary heart disease risk but not stroke in women. Eur. J. Clin. Nutr. 59:196-204
46. Farzaneh-Far A, Davies JD, Braam LA, Spronk HM, Proudfoot D, et al. 2001. A polymorphism of the human matrix gamma-carboxyglutamic acid protein promoter alters binding of an activating protein-1 complex and is associated with altered transcription and serum levels. J. Biol. Chem. 276:32466-73
47. Ferron M, Hinoi E, Karsenty G, Ducy P. 2008. Osteocalcin differentially regulates beta cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice. Proc. Natl. Acad. Sci. USA 105:5266-70
48. Feskanich D, Weber P, Willett WC, Rockett H, Booth SL, Colditz GA. 1999. Vitamin K intake and hip fractures in women: a prospective study. Am. J. Clin. Nutr. 69:74-79
49. Fewtrell MS, Benden C, Williams JE, Chomtho S, Ginty F, et al. 2008. Undercarboxylated osteocalcin and bone mass in 8-12-year-old children with cystic fibrosis. J. Cyst. Fibros. 7:307-12
50. Geleijnse JM, Vermeer C, Grobbee DE, Schurgers LJ, Knapen MH, et al. 2004. Dietary intake of menaquinone is associated with a reduced risk of coronary heart disease: the Rotterdam Study. J. Nutr. 134:3100-5
51. Gundberg CM, Nieman SD, Abrams S, Rosen H. 1998. Vitamin K status and bone health: an analysis of methods for determination of undercarboxylated osteocalcin. J. Clin. Endocrinol. Metab. 83:3258-66
52. Hamilton DW. 2008. Functional role of periostin in development and wound repair: implications for connective tissue disease. J. Cell Commun. Signal. 2:9-17
53. Hara K, Akiyama Y, Nakamura T, Murota S, Morita I. 1995. The inhibitory effect of vitamin K2 (menatetrenone) on bone resorption may be related to its side chain. Bone 16:179-84
54. Harrington DJ, Booth SL, Card DJ, Shearer MJ. 2007. Excretion of the urinary 5C- and 7C-aglycone metabolites of vitamin K by young adults responds to changes in dietary phylloquinone and dihydrophylloquinone intakes. J. Nutr. 137:1763-68
55. Heiss C, Hoesel LM, Wehr U, Wenisch S, Drosse I, et al. 2008. Diagnosis of osteoporosis with vitamin K as a new biochemical marker. Vitam. Horm. 78:417-34
56. Herrmann SM, Whatling C, Brand E, Nicaud V, Gariepy J, et al. 2000. Polymorphisms of the human matrix Gla protein (MGP) gene, vascular calcification, and myocardial infarction. Arterioscler. Thromb. Vasc. Biol. 20:2386-93
57. Hesketh J. 2008. Nutrigenomics and selenium: gene expression patterns, physiological targets, and genetics. Annu. Rev. Nutr. 28:157-77
58. Hur DJ, Raymond GV, Kahler SG, Riegert-Johnson DL, Cohen BA, Boyadjiev SA. 2005. A novel MGP mutation in a consanguineous family: review of the clinical and molecular characteristics of Keutel syndrome. Am. J. Med. Genet. A 135:36-40
59. Ikeda Y, Iki M, Morita A, Kajita E, Kagamimori S, et al. 2006. Intake of fermented soybeans, natto, is associated with reduced bone loss in postmenopausal women: Japanese Population-Based Osteoporosis Study ( JPOS). J. Nutr. 136:1323-28
60. Iwamoto J, Takeda T, Sato Y. 2006. Role of vitamin K2 in the treatment of postmenopausal osteoporosis. Curr. Drug Saf. 1:87-97
61. Jie KS, Bots ML, Vermeer C, Witteman JC, Grobbee DE. 1995. Vitamin K intake and osteocalcin levels in women with and without aortic atherosclerosis: a population-based study. Atherosclerosis 116:117-23
62. Jono S, Ikari Y, Vermeer C, Dissel P, Hasegawa K, et al. 2004. Matrix Gla protein is associated with coronary artery calcification as assessed by electron-beam computed tomography. Thromb. Haemost. 91:790-94
63. Kalkwarf HJ, Khoury JC, Bean J, Elliot JG. 2004. Vitamin K, bone turnover, and bone mass in girls. Am. J. Clin. Nutr. 80:1075-80
64. Kamao M, Suhara Y, Tsugawa N, Uwano M, Yamaguchi N, et al. 2007. Vitamin K content of foods and dietary vitamin K intake in Japanese young women. J. Nutr. Sci. Vitaminol. (Tokyo) 53:464-70
65. Kameda T, Miyazawa K, Mori Y, Yuasa T, Shiokawa M, et al. 1996. Vitamin K2 inhibits osteoclastic bone resorption by inducing osteoclast apoptosis. Biochem. Biophys. Res. Commun. 220:515-19
66. Katsuyama H, Ideguchi S, Fukunaga M, Saijoh K, Sunami S. 2002. Usual dietary intake of fermented soybeans (natto) is associated with bone mineral density in premenopausal women. J. Nutr. Sci. Vitaminol. (Tokyo) 48:207-15
67. Katsuyama H, Otsuki T, Tomita M, Fukunaga M, Fukunaga T, et al. 2005. Menaquinone-7 regulates the expressions of osteocalcin, OPG, RANKL and RANK in osteoblastic MC3T3E1 cells. Int. J. Mol. Med. 15:231-36
68. Kawana K, Takahashi M, Hoshino H, Kushida K. 2001. Circulating levels of vitamin K1, menaquinone-4, and menaquinone-7 in healthy elderly Japanese women and patients with vertebral fractures and patients with hip fractures. Endocr. Res. 27:337-43
69. Kimura R, Miyashita K, Kokubo Y, Akaiwa Y, Otsubo R, et al. 2007. Genotypes of vitamin K epoxide reductase, gamma-glutamyl carboxylase, and cytochrome P450 2C9 as determinants of daily warfarin dose in Japanese patients. Thromb. Res. 120:181-86
70. Knapen MH, Nieuwenhuijzen-Kruseman AC, Wouters RSME, Vermeer C. 1998. Correlation of serum osteocalcin fractions with bone mineral density in women during the first 10 years after menopause. Calcif. Tissue Int. 63:375-79
71. Knapen MH, Schurgers LJ, Vermeer C. 2007. Vitamin K2 supplementation improves hip bone geometry and bone strength indices in postmenopausal women. Osteoporos. Int. 18:963-72
72. Kobayashi M, Hara K, Akiyama Y. 2004. Effects of vitamin K2 (menatetrenone) and alendronate on bone mineral density and bone strength in rats fed a low-magnesium diet. Bone 35:1136-43
73. Kobayashi N, Kitazawa R, Maeda S, Schurgers L, Kitazawa S. 2004. T-138C polymorphism of matrix Gla protein promoter alters its expression but is not directly associated with atherosclerotic vascular calcification. Kobe J. Med. Sci. 50:69-81
74. Kohlmeier M, Salomon A, Saupe J, Shearer MJ. 1996. Transport of vitamin K to bone in humans. J. Nutr. 126:1192-96S
75. Koshihara Y, Hoshi K, Ishibashi H, Shiraki M. 1996. Vitamin K2 promotes 1alpha,25(OH)2 vitamin D3-induced mineralization in human periosteal osteoblasts. Calcif. Tissue Int. 59:466-73
76. Koshihara Y, Hoshi K, Shiraki M. 1993. Vitamin K2 (menatetrenone) inhibits prostaglandin synthesis in cultured human osteoblast-like periosteal cells by inhibiting prostaglandin H synthase activity. Biochem. Pharmacol. 46:1355-62
77. Lee NK, Sowa H, Hinoi E, Ferron M, Ahn JD, et al. 2007. Endocrine regulation of energy metabolism by the skeleton. Cell 130:456-69
78. Levy RJ, Lian JB, Gallop P. 1979. Atherocalcin, a gamma-carboxyglutamic acid containing protein from atherosclerotic plaque. Biochem. Biophys. Res. Commun. 91:41-49
79. Levy RJ, Zenker JA, Lian JB. 1980. Vitamin K-dependent calcium binding proteins in aortic valve calcification. J. Clin. Invest. 65:563-66
80. Lian JB, Skinner M, Glimcher MJ, Gallop P. 1976. The presence of gamma-carboxyglutamic acid in the proteins associated with ectopic calcification. Biochem. Biophys. Res. Commun. 73:349-55
81. Lukacs JL, Booth S, Kleerekoper M, Ansbacher R, Rock CL, Reame NE. 2006. Differential associations for menopause and age in measures of vitamin K, osteocalcin, and bone density: a cross-sectional exploratory study in healthy volunteers. Menopause 13:799-808
82. Luo G, Ducy P, McKee MD, Pinero GJ, Loyer E, et al. 1997. Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature 386:78-81
83. Luukinen H, Kakonen SM, Pettersson K, Koski K, Laippala P, et al. 2000. Strong prediction of fractures among older adults by the ratio of carboxylated to total serum osteocalcin. J. Bone Miner. Res. 15:2473-78
84. Maas AH, Van Der Schouw YT, Beijerinck D, Deurenberg JJ, Mali WP, et al. 2007. Vitamin K intake and calcifications in breast arteries. Maturitas 56:273-79
85. Macdonald HM, McGuigan FE, Lanham-New SA, Fraser WD, Ralston SH, Reid DM. 2008. Vitamin K1 intake is associated with higher bone mineral density and reduced bone resorption in early postmenopausal Scottish women: no evidence of gene-nutrient interaction with apolipoprotein E polymorphisms. Am. J. Clin. Nutr. 87:1513-20
86. Murshed M, Schinke T, McKee MD, Karsenty G. 2004. Extracellular matrix mineralization is regulated locally; different roles of two Gla-containing proteins. J. Cell Biol. 165:625-30
87. Nakao M, Nishiuchi Y, Nakata M, Kimura T, Sakakibara S. 1994. Synthesis of human osteocalcins: gamma-carboxyglutamic acid at position 17 is essential for a calcium-dependent conformational transition. Pept. Res. 7:171-74
88. O'Connor E, Molgaard C, Michaelsen KF, Jakobsen J, Lamberg-Allardt CJ, Cashman KD. 2007. Serum percentage undercarboxylated osteocalcin, a sensitive measure of vitamin K status, and its relationship to bone health indices in Danish girls. Br. J. Nutr. 97:661-66
89. O'Donnell CJ, Shea MK, Price PA, Gagnon DR, Wilson PW, et al. 2006. Matrix Gla protein is associated with risk factors for atherosclerosis but not with coronary artery calcification. Arterioscler. Thromb. Vasc. Biol. 26:2769-74
90. Ohsaki Y, Shirakawa H, Hiwatashi K, Furukawa Y, Mizutani T, Komai M. 2006. Vitamin K suppresses lipopolysaccharide-induced inflammation in the rat. Biosci. Biotechnol. Biochem. 70:926-32
91. Okano T, Shimomura Y, Yamane M, Suhara Y, Kamao M, et al. 2008. Conversion of phylloquinone (vitamin K1) into menaquinone-4 (vitamin K2) in mice: two possible routes for menaquinone-4 accumulation in cerebra of mice. J. Biol. Chem. 283:11270-79
92. Philip WJ, Martin JC, Richardson JM, Reid DM, Webster J, Douglas AS. 1995. Decreased axial and peripheral bone density in patients taking long-term warfarin. QJM 88:635-40
93. Presse N, Shatenstein B, Kergoat MJ, Ferland G. 2008. Low vitamin K intakes in community-dwelling elders at an early stage of Alzheimer's disease. J. Am. Diet. Assoc. 108:2095-99
94. Price P, Faus S, Williamson M. 1998. Warfarin causes rapid calcification of the elasetic lamellae in rat arteries and heart valves. Arterioscler. Thromb. Vasc. Biol. 18:1400-7
95. Proudfoot D, Shanahan CM. 2006. Molecular mechanisms mediating vascular calcification: role of matrix Gla protein. Nephrology 11:455-61
96. Prynne CJ, Thane CW, Prentice A, Wadsworth ME. 2005. Intake and sources of phylloquinone (vitamin K(1)) in 4-year-old British children: comparison between 1950 and the 1990s. Public Health Nutr. 8:171-80
97. Reaven GM. 2005. The insulin resistance syndrome: definition and dietary approaches to treatment. Annu. Rev. Nutr. 25:391-406
98. Reddi K, Henderson B, Meghji S, Wilson M, Poole S, et al. 1995. Interleukin 6 production by lipopolysaccharide-stimulated human fibroblasts is potently inhibited by naphthoquinone (vitamin K) compounds. Cytokine 7:287-90
99. Sakamoto N, Nishiike T, Iguchi H, Sakamoto K. 1999. Relationship between acute insulin response and vitamin K intake in healthy young male volunteers. Diabetes Nutr. Metab. 12:37-41
100. Sakamoto N, Nishiike T, Iguchi H, Sakamoto K. 2000. Possible effects of one week vitamin K (menaquinone-4) tablets intake on glucose tolerance in healthy young male volunteers with different descarboxy prothrombin levels. Clin. Nutr. 19:259-63
101. Sakamoto N, Wakabayashi I, Sakamoto K. 1999. Low vitamin K intake effects on glucose tolerance in rats. Int. J. Vitam. Nutr. Res. 69:27-31
102. Sato Y, Honda Y, Hayashida N, Iwamoto J, Kanoko T, Satoh K. 2005. Vitamin K deficiency and osteopenia in elderly women with Alzheimer's disease. Arch. Phys. Med. Rehabil. 86:576-81
103. Sato Y, Honda Y, Kunoh H, Oizumi K. 1997. Long-term oral anticoagulation reduces bone mass in patients with previous hemispheric infarction and nonrheumatic atrial fibrillation. Stroke 28:2390-94
104. Schaafsma A, Muskiet FA, Storm H, Hofstede GJ, Pakan I, Van Der Veer E. 2000. Vitamin D(3) and vitamin K(1) supplementation of Dutch postmenopausal women with normal and low bone mineral densities: effects on serum 25-hydroxyvitamin D and carboxylated osteocalcin. Eur. J. Clin. Nutr. 54:626-31
105. Schett G, Kiechl S, Weger S, Pederiva A, Mayr A, et al. 2006. High-sensitivity C-reactive protein and risk of nontraumatic fractures in the Bruneck study. Arch. Intern. Med. 166:2495-501
106. Schurgers LJ, Spronk HM, Soute BA, Schiffers PM, DeMey JG, Vermeer C. 2007. Regression of warfarin-induced medial elastocalcinosis by high intake of vitamin K in rats. Blood 109:2823-31
107. Schurgers LJ, Teunissen KJ, Knapen MH, Kwaijtaal M, van Diest R, et al. 2005. Novel conformation-specific antibodies against matrix gamma- carboxyglutamic acid (Gla) protein: undercarboxylated matrix Gla protein as marker for vascular calcification. Arterioscler. Thromb. Vasc. Biol. 25:1629-33
108. Schurgers LJ, Vermeer C. 2000. Determination of phylloquinone and menaquinones in food. Effect of food matrix on circulating vitamin K concentrations. Haemostasis 30:298-307
109. Shanahan CM, Cary NR, Metcalfe JC, Weissberg PL. 1994. High expression of genes for calcification-regulating proteins in human atherosclerotic plaques. J. Clin. Invest. 93:2393-402
110. Shea MK, Benjamin EJ, Dupuis J, Massaro JM, Jacques PF, et al. 2007. Genetic and non-genetic correlates of vitamins K and D. Eur. J. Clin. Nutr. doi:10.1038/sj.ejcn.1602959
111. Shea MK, Booth SL. 2008. Update on the role of vitamin K in skeletal health. Nutr. Rev. 66:549-57
112. Shea MK, Dallal GE, Dawson-Hughes B, Ordovas JM, O'Donnell CJ, et al. 2008. Vitamin K, circulating cytokines, and bone mineral density in older men and women. Am. J. Clin. Nutr. 88:356-63
113. Shearer MJ, Newman P. 2008. Metabolism and cell biology of vitamin K. Thromb. Haemost. 100:530-47
114. Song Y, Vera N, Kohn MH. 2008. Vitamin K epoxide reductase complex subunit 1 (Vkorc1) haplotype diversity in mouse priority strains. BMC Res. Notes 1:125
115. Stenberg LM, Nilsson E, Ljungberg O, Stenflo J, Brown MA. 2001. Synthesis of gamma-carboxylated polypeptides by alpha-cells of the pancreatic islets. Biochem. Biophys. Res. Commun. 283:454-59
116. Suttie JW. 1995. The importance of menaquinones in human nutrition. Annu. Rev. Nutr. 15:399-417
117. Szulc P, Chapuy MC, Meunier PJ, Delmas PD. 1993. Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture in elderly women. J. Clin. Invest. 91:1769-74
118. Szulc P, Chapuy MC, Meunier PJ, Delmas PD. 1996. Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture: a three year follow-up study. Bone 18:487-88
119. Tamura T, Morgan SL, Takimoto H. 2007. Vitamin K and the prevention of fractures. Arch. Intern. Med. 167:94
120. Taylor BC, Schreiner PJ, Doherty TM, Fornage M, Carr JJ, Sidney S. 2005. Matrix Gla protein and osteopontin genetic associations with coronary artery calcification and bone density: the CARDIA study. Hum. Genet. 116:525-28
121. Thane CW, Bolton-Smith C, Coward WA. 2006. Comparative dietary intake and sources of phylloquinone (vitamin K1) among British adults in 1986-7 and 2000-1. Br. J. Nutr. 96:1105-15
122. Thijssen HH, Drittij-Reijnders MJ. 1996. Vitamin K status in human tissues: tissue-specific accumulation of phylloquinone and menaquinone-4. Br. J. Nutr. 75:121-27
123. Thijssen HH, Vervoort LM, Schurgers LJ, Shearer MJ. 2006. Menadione is a metabolite of oral vitamin K. Br. J. Nutr. 95:260-66
124. Tilg H, Moschen AR. 2008. Insulin resistance, inflammation, and non-alcoholic fatty liver disease. Trends Endocrinol. Metab. 19:371-79
125. Tsugawa N, Shiraki M, Suhara Y, Kamao M, Ozaki R, et al. 2008. Low plasma phylloquinone concentration is associated with high incidence of vertebral fracture in Japanese women. J. Bone Miner. Metab. 26:79-85
126. Vallarta-Ast N, Kreuger D, Suttie J, Binkley N. 2008. Vitamin K treatment for one year does not alter femure geometry in postmenopausal women. J. Bone Miner. Res. 23:S217
127. van Summeren MJ, van Coeverden SC, Schurgers LJ, Braam LA, Noirt F, et al. 2008. Vitamin K status is associated with childhood bone mineral content. Br. J. Nutr. 100:852-58
128. Vergnaud P, Garnero P, Meunier PJ, Breart G, Kamihagi K, Delmas PD. 1997. Undercarboxylated osteocalcin measured with a specific immunoassay predicts hip fracture in elderly women: the EPIDOS Study. J. Clin. Endocrinol. Metab. 82:719-24
129. Vermeer C, Jie KS, Knapen MH. 1995. Role of vitamin K in bone metabolism. Annu. Rev. Nutr. 15:1-22
130. Viegas CS, Simes DC, Laize V, Williamson MK, Price PA, Cancela ML. 2008. GLA-rich protein (GRP): a new vitamin K-dependent protein identified from sturgeon cartilage and highly conserved in vertebrates. J. Biol. Chem. 283:36655-64
131. Villines TC, Hatzigeorgiou C, Feuerstein IM, O'Malley PG, Taylor AJ. 2005. Vitamin K1 intake and coronary calcification. Coron. Artery Dis. 16:199-203
132. Wadelius M, Chen LY, Downes K, Ghori J, Hunt S, et al. 2005. Common VKORC1 and GGCX polymorphisms associated with warfarin dose. Pharmacogenomics J. 5:262-70
133. Wang Y, Zhang W, Zhang Y, Yang Y, Sun L, et al. 2006. VKORC1 haplotypes are associated with arterial vascular diseases (stroke, coronary heart disease, and aortic dissection). Circulation 113:1615-21
134. Watzka M, Nebel A, El Mokhtari NE, Ivandic B, Muller J, et al. 2007. Functional promoter polymorphism in the VKORC1 gene is no major genetic determinant for coronary heart disease in Northern Germans. Thromb. Haemost. 97:998-1002
135. Woo C, Chang LL, Ewing SK, Bauer DC. 2008. Single-point assessment of warfarin use and risk of osteoporosis in elderly men. J. Am. Geriatr. Soc. 56:1171-76
136. Yaegashi Y, Onoda T, Tanno K, Kuribayashi T, Sakata K, Orimo H. 2008. Association of hip fracture incidence and intake of calcium, magnesium, vitamin D, and vitamin K. Eur. J. Epidemiol. 23:219-25
137. Yan L, Zhou B, Greenberg D, Wang L, Nigdikar S, et al. 2004. Vitamin K status of older individuals in northern China is superior to that of older individuals in the UK. Br. J. Nutr. 92:939-45
138. Yasui T, Uemura H, Tomita J, Miyatani Y, Yamada M, et al. 2007. Change in serum undercarboxylated osteocalcin concentration in bilaterally oophorectomized women. Maturitas 56:288-96
139. Yasui T, Uemura H, Tomita J, Umino Y, Yamada M, et al. 2006. Different effects of oral conjugated equine estrogens and transdermal estrogen on undercarboxylated osteocalcin concentration in postmenopausal women. Menopause 13:651-59
140. Yoshida M, Booth SL, Meigs JB, Saltzman E, Jacques PF. 2008. Phylloquinone intake, insulin sensitivity, and glycemic status in men and women. Am. J. Clin. Nutr. 88:210-15
141. Yoshida M, Jacques PF, Meigs JB, Saltzman E, Shea MK, et al. 2008. Effect of vitamin K supplementation on insulin resistance in older men and women. Diabetes Care 31:2092-96
142. Zajickova K, Zofkova I, Hill M, Horinek A, Novakova A. 2003. Apolipoprotein E 4 allele is associated with low bone density in postmenopausal women. J. Endocrinol. Invest. 26:312-15